1. Home
  2. PATK vs SUPN Comparison

PATK vs SUPN Comparison

Compare PATK & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Patrick Industries Inc.

PATK

Patrick Industries Inc.

N/A

Current Price

$77.30

Market Cap

2.2B

ML Signal

N/A

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

N/A

Current Price

$42.43

Market Cap

2.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PATK
SUPN
Founded
1959
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.5B
IPO Year
1994
2010

Fundamental Metrics

Financial Performance
Metric
PATK
SUPN
Price
$77.30
$42.43
Analyst Decision
Buy
Buy
Analyst Count
11
4
Target Price
★ $98.27
$60.50
AVG Volume (30 Days)
759.4K
★ 912.1K
Earning Date
10-29-2026
10-29-2026
Dividend Yield
★ 2.50%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 2.37
N/A
Revenue
$29,000,000.00
★ $392,755,000.00
Revenue This Year
N/A
$21.56
Revenue Next Year
$4.76
$55.45
P/E Ratio
$31.83
★ N/A
Revenue Growth
★ 262.50
N/A
52 Week Low
$63.00
$37.54
52 Week High
$148.50
$59.68

Technical Indicators

Market Signals
Indicator
PATK
SUPN
Relative Strength Index (RSI) 66.76 53.06
Support Level $63.00 $41.86
Resistance Level $89.83 $51.59
Average True Range (ATR) 2.87 2.13
MACD 1.51 0.23
Stochastic Oscillator 98.28 70.75

Price Performance

Historical Comparison
PATK
SUPN

About PATK Patrick Industries Inc.

Patrick Industries Inc is a component solutions provider for the recreational vehicle (RV), marine, powersports, manufactured housing (MH), and various industrial markets, including single and multi-family housing, hospitality, institutional, and commercial markets. The company operates within two reportable segments, Manufacturing and Distribution. The majority of its revenue is generated from the Manufacturing segment, which offers laminated products utilized to produce furniture, shelving, walls, and countertops; fabricated aluminum products; cabinet products, doors, components, and custom cabinetry; interior passage doors and baggage doors; RV and marine furniture, etc. Geographically, the company mainly operates in the United States, with a small presence in Mexico, China, and Canada.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: